Blocking the excitotoxicity induced by the interaction between tPA with NMDA receptors: an antibody-based therapy in multiple sclerosis

被引：0
|
作者：
Macrez, R. [1 ]
Montagne, A. [1 ]
Gauberti, M. [1 ]
Toutirais, O. [1 ]
Le Mauff, B. [1 ]
Vivien, D. [1 ]
Docagne, F. [1 ]
Defer, G. [1 ]
机构：
[1] INSERM, U919, Caen, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P180
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 42 条
  • [1] Antibody-based therapy for multiple myeloma
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2022, 21 (4) : 260 - 260
  • [2] Eph receptors as cancer targets for antibody-based therapy
    Tang, Fenny H. F.
    Davis, Deodate
    Arap, Wadih
    Pasqualini, Renata
    Staquicini, Fernanda I.
    RECEPTOR TYROSINE KINASES, 2020, 147 : 303 - 317
  • [3] Antibody-based profiling of cerebrospinal fluid within multiple sclerosis
    Haggmark, Anna
    Bystrom, Sanna
    Ayoglu, Burcu
    Qundos, Ulrika
    Uhlen, Mathias
    Khademi, Mohsen
    Olsson, Tomas
    Schwenk, Jochen M.
    Nilsson, Peter
    PROTEOMICS, 2013, 13 (15) : 2256 - 2267
  • [4] Antibody-based cancer therapy toward multiple target molecules
    Okita, Kouki
    Yamasaki, Akitaka
    Tomioka, Yoshihisa
    Nagai, Noriaki
    Masuko, Takashi
    CANCER SCIENCE, 2024, 115 : 2062 - 2062
  • [5] Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma
    N W C J van de Donk
    S Kamps
    T Mutis
    H M Lokhorst
    Leukemia, 2012, 26 : 199 - 213
  • [6] Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma
    Stadtmauer, Edward A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (04): : 368 - 369
  • [7] Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma
    van de Donk, N. W. C. J.
    Kamps, S.
    Mutis, T.
    Lokhorst, H. M.
    LEUKEMIA, 2012, 26 (02) : 199 - 213
  • [8] Engineering T-cells with antibody-based chimeric receptors for effective cancer therapy
    Thistlethwaite, F
    Mansoor, W
    Gilham, DE
    Hawkins, RE
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (01) : 48 - 55
  • [9] Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
    Mari Iida
    Toni M Brand
    Megan M Starr
    Evan J Huppert
    Neha Luthar
    Harsh Bahrar
    John P Coan
    Hannah E Pearson
    Ravi Salgia
    Deric L Wheeler
    Molecular Cancer, 13
  • [10] Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
    Iida, Mari
    Brand, Toni M.
    Starr, Megan M.
    Huppert, Evan J.
    Luthar, Neha
    Bahrar, Harsh
    Coan, John P.
    Pearson, Hannah E.
    Salgia, Ravi
    Wheeler, Deric L.
    MOLECULAR CANCER, 2014, 13
12345